Are your Wearables Worthy? Bust the myths of ‘validation’ and embrace wearables for your virtual trials

The promise of wearables has always been clear. It’s time to deliver on that promise.

COVID-19 and the imminent rise of 5G networks are an accelerant, deepening our commitment to the use of wearables and sensors to capture better digital endpoints remotely.

This free webinar provides essential guidelines to ensure that even as we move quickly, we start with the end in mind and take a comprehensive approach to managing complexity. A panel of experts from ActiGraph, VivoSense, Takeda, and Novartis discuss key differences between standard COA validation and sensor validation, and why it’s so important to appreciate the nuances of verification, analytical validation, and clinical validation of a wearable measure.

We also see why we need to get these fundamentals right before deploying AI and ML and discuss best practice implementation to maximize the value of your data in the long term.

Jeremy Wyatt, ActiGraph
Kate Lyden, VivoSense
Ariel Dowling, Takeda
Abhi Verma, Novartis

Register to view webinar

Your information will be used to send you periodic communications from ActiGraph. You can change your mind by clicking the unsubscribe link at the bottom of emails you receive from us.